Clinical trial NCT03231449: A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
Official title: A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Acute Coronary Syndrome
Heart Failure
Syncope
Stroke
Pericarditis
Endocarditis
Conduction Abnormalities
Rhythm; Abnormal
Pulmonary Embolism
Deep Vein Thrombosis
Other Cardiovascular Conditions
Keywords: routine care, evaluation, Africa, observatory
Lead sponsor: Cardiologie et Développement
Sponsor class: OTHER
Collaborators: name: Institut National de la Santé Et de la Recherche Médicale, France
First posted: 2017-07-27
Enrollment: 5000
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Each patient hospitalized in cardiology unit of participating centers during the month of February can be included.

Brief summary: FEVRIER study is an observatory of hospitalizations in cardiology units in sub-Saharan Africa.

Detailed description: FEVRIER is an observational study based on a questionnaire completed by investigators for each hospitalization in cardiology unit during the month of February.The investigator is a physician of the participating hospital.

FEVRIER evaluates the modalities of care management. It will take place in cardiology units of hospitals of sub-Saharian countries one month per year (month of February) during 5 years.

The investigator will thoroughly complete:

* one information form describing the hospital and the department
* one questionnaire (2o questions) for each hospitalized patient

Patients with at least one day of hospitalization will be enrolled in the study. On the first day of February, all patients already hospitalized will be enrolled and all patients hospitalized in the last day of February will be followed until their discharge. thus, data collection will start 1st day of investigation, during February and will continue until the discharge of the last enrolled patient.

Eligibility criteria: Inclusion Criteria:

* to be hospitalized in a cardiology department of a participating center during the month of February

Exclusion Criteria:

* refusal

Primary outcomes:
measure: Description of patients in cardiology unit in sub-Saharan Africa:socio-demographic characterization
timeFrame: 5 years
measure: Description of patients in cardiology unit in sub-Saharan Africa:causes of hospitalization
timeFrame: 5 years
measure: Description of patients in cardiology unit in sub-Saharan Africa: co-morbidities
timeFrame: 5 years
measure: Description of patients in cardiology unit in sub-Saharan Africa: hospital examinations
timeFrame: 5 years
measure: Description of patients in cardiology unit in sub-Saharan Africa: duration of hospitalization
timeFrame: 5 years
measure: Description of patients in cardiology unit in sub-Saharan Africa: discharge diagnosis
timeFrame: 5 years
Secondary outcomes:
measure: number of patients with heart failure
timeFrame: 5 years
measure: number of patients with myocardial infarction
timeFrame: 5 years
measure: number of patients with atrial fibrillation
timeFrame: 5 years
Other outcomes:
Locations:
city: Cotonou
country: Benin
facility: Centre national hospitalier et universitaire Koutoukou Maga
city: Ouagadougou
country: Burkina Faso
facility: Centre médical Paul IV
city: Bujumbura
country: Burundi
facility: Hopital militaire de Kamenge et polyclinique maison médicale
city: Bafoussam
country: Cameroon
facility: Hôpital Régional
city: Douala
country: Cameroon
facility: Douala General Hospital
city: Yaounde
country: Cameroon
facility: Central Hospital
city: Yaounde
country: Cameroon
facility: Hôpital Général de Yaoundé
city: Kinshasa
country: Congo, The Democratic Republic of the
facility: Clinique Ngaliema
city: Kinshasa
country: Congo, The Democratic Republic of the
facility: Clinique universitaire de Kinshasa
city: Brazzaville
country: Congo
facility: CHU
city: Abidjan
country: Côte D'Ivoire
facility: Institut de Cariologie d'Abidjan
city: Bouake
country: Côte D'Ivoire
facility: CHU
city: Libreville
country: Gabon
facility: Centre Hospitalier Universitaire (CHUL)
city: Conakry
country: Guinea
facility: CHU Ignace Deen
city: Maputo
country: Mozambique
facility: Institut du coeur
city: Niamey
country: Niger
facility: Hôpital National Lamorde
city: Dakar
country: Senegal
facility: Hôpital de Fann
city: Dakar
country: Senegal
facility: Hôpital général de Grand Yoff
city: Kaolac
country: Senegal
facility: El Hadj-Ibrahima Niass
city: Khartoum
country: Sudan
facility: National Cardiothoracic center / Shab Teaching Hospital
Study officials:
affiliation: cardiologie et Developpement
name: Xavier Jouven, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007 Aug 2;357(5):470-6. doi: 10.1056/NEJMoa065085.
citation: Marijon E, Celermajer DS, Tafflet M, El-Haou S, Jani DN, Ferreira B, Mocumbi AO, Paquet C, Sidi D, Jouven X. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation. 2009 Aug 25;120(8):663-8. doi: 10.1161/CIRCULATIONAHA.109.849190. Epub 2009 Aug 10.
citation: Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012 Mar 10;379(9819):953-964. doi: 10.1016/S0140-6736(11)61171-9.
citation: Ranque B, Menet A, Diop IB, Thiam MM, Diallo D, Diop S, Diagne I, Sanogo I, Kingue S, Chelo D, Wamba G, Diarra M, Anzouan JB, N'Guetta R, Diakite CO, Traore Y, Legueun G, Deme-Ly I, Belinga S, Boidy K, Kamara I, Tharaux PL, Jouven X. Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study. Lancet Haematol. 2014 Nov;1(2):e64-73. doi: 10.1016/S2352-3026(14)00007-6. Epub 2014 Oct 28.
citation: Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Sidi D, Jouven X. Echocardiographic screening for rheumatic heart disease. Bull World Health Organ. 2008 Feb;86(2):84. doi: 10.2471/blt.07.046680. No abstract available.
citation: Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Iqbal R, Rahman O, Rosengren A, Yusufali A, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Oguz A, McQueen M, McKee M, Dagenais G; PURE Investigators. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014 Aug 28;371(9):818-27. doi: 10.1056/NEJMoa1311890.